SCHEMBL1632711

SCHEMBL1632711

NS(=O)(=O)c1ccc(Nc2ncc3cccc(CN4CCNC(=O)C4)c3n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 4/20 0.46
▸ CA1 P00915 3/20 0.46
▸ CA9 Q16790 3/20 0.46
▸ CDK2 P24941 7/20 0.43
▸ CCNT1 O60563 7/20 0.43
▸ CDK1 P06493 7/20 0.43
▸ CDK9 P50750 7/20 0.43
▸ CDK7 P50613 5/20 0.43
▸ IKBKB O14920 3/20 0.43
▸ CCNB1 P14635 2/20 0.43
▸ CCNH P51946 2/20 0.43
▸ CHUK O15111 1/20 0.43
▸ STK4 Q13043 2/20 0.43
▸ CCNE1 P24864 6/20 0.42
▸ CDK4 P11802 5/20 0.42
▸ CCNA2 P20248 5/20 0.42
▸ CCND1 P24385 5/20 0.42
▸ CCND3 P30281 5/20 0.42
▸ CDK3 Q00526 5/20 0.42
▸ CDK6 Q00534 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633835 0.85 IKBKB (0.47) CA2CA1CA9CDK2CCNT1
SCHEMBL1632740 0.84 CYP11B2 (0.42) CA2CA1CA9CDK2CCNT1
SCHEMBL1633063 0.83 IKBKB (0.53) CA2CA1CA9CDK2CCNT1
SCHEMBL1633031 0.82 FGFR4 (0.47) CA2CA1CA9CDK2CCNT1
SCHEMBL1632397 0.82 TBK1 (0.57) CA2CA1CA9CDK2CCNT1
SCHEMBL1632154 0.80 CDK2 (0.46) CA2CA1CA9CDK2CCNT1
SCHEMBL1632479 0.79 MTOR (0.45) CA2CA1CA9CDK2CCNT1
SCHEMBL1631354 0.79 TYK2 (0.54) CA2CA1CA9CDK2CCNT1
SCHEMBL1633709 0.78 SYK (0.47) CA2CDK2CCNT1CDK1CDK9
SCHEMBL1633356 0.77 CDK1 (0.44) CA2CDK2CDK1CDK9IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback